Blood product transfusions are associated with an increase in serum (1-3)-beta- d -glucan in infants during the initial hospitalization in neonatal intensive care unit (NICU)
Authors:
- 8 June 2016
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 30 (8) , 933-937
Abstract
Introduction: Serum (1-3)-beta-d-glucan (BDG) assay has been proposed as an adjunct for the rapid diagnosis of invasive fungal infection (IFI). However, false-positive results have been reported following transfusion of blood products in adults. Aims: To assess the relationship between blood product transfusion and elevated BDG in neonates. Method: Retrospective study including neonates ≤32 weeks, with no fungal colonization or infection, in whom BDG assay was performed for suspicion of IFI. Patients were classified in Transfusion (n = 78) and No Transfusion (n = 55) groups depending on whether or not they were transfused. Clinical, biochemical and microbiological characteristics were recorded. A BDG assay >80 pg/mL was considered as positive. Statistical analyses: bivariate and multivariate logistic regression. Results (median, IQR): One hundred and thirty-three infants were included (gestational age 28.4 weeks, 26.9–30; birth weight 1000 g, 847–1300). BDG was higher in the Transfusion group (170 pg/mL, 65–317) than in the No Transfusion group (57 pg/mL, 34–108; p < 0.001). False-positive BDG assay results were associated with red blood cells (RBC) and fresh frozen plasma (FFP) transfusions. Conclusion: BDG is increased after RBC and FFP transfusions in neonates, leading to overdiagnosis of IFI. Fungal colonization status in peripheral sites and central cultures could help to reduce the risk of misdiagnosis.Keywords
This publication has 27 references indexed in Scilit:
- (1–3)-β-D-glucan levels in candidiasis infections in the critically ill neonateThe Journal of Maternal-Fetal & Neonatal Medicine, 2012
- Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Acquired bloodstream infection in the intensive care unit: incidence and attributable mortalityCritical Care, 2011
- Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal TherapyInternational Journal of Pediatrics, 2011
- Neonatal Candidiasis: Epidemiology, Risk Factors, and Clinical JudgmentPediatrics, 2010
- Difficulties in using 1,3-β-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of false-positive results and their analysisJournal of Medical Microbiology, 2010
- Measurement of (1-3)-.BETA.-D-Glucan Derived from Different Gauze TypesThe Tohoku Journal of Experimental Medicine, 2009
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008
- Risk Factors for Progression to Invasive Fungal Infection in Preterm Neonates With Fungal ColonizationPediatrics, 2006
- Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyClinical Infectious Diseases, 2006